Professor
Jiangsu Province Hospital
Nanjing, Jiangsu, China (People's Republic)
Dr. Wang is the pioneer to introduce biotechnology and biopharmaceuticals into China, funded several drug and device companies in US/China. He guided key animal experiments in US and first-in-human studies in China to prove the concept of Ardian’s renal denervation therapy for hypertension. He has been awarded "CRT 2012 Best Innovation Award" due to his patents of renal sympathetic nerve mapping/ablation devices. He is co-founder and President of SyMap Medical Ltd and was the Vice President, Jiangsu Academy of Clinical and Translational Research, Jiangsu Province Hospital; he was an associate professor at College of P&S, Columbia University and still holds a faculty position at CUMC. He published more than 100 peer-reviewed articles and holds more than 50 patents.He obtained MD from Hebei Medical College and PhD from New York Medical College, completed fellowship training at Duke and Harvard University.
Disclosure information not submitted.
Pivotal Trial of Renal Mapping/Selective RDN To Treat Hypertension: Results at 6 Months
Sunday, March 10, 2024
4:12 PM – 4:20 PM ET
Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation
Sunday, March 10, 2024
5:32 PM – 5:45 PM ET